VHI

1 result

The drugs VHI has committed to providing wider access to include Pembrolizumab, for stage three melanoma, and Pertuzumab (Perjeta) for patients with early stage breast cancer.  Photograph: Istock

Access to new cancer drugs for some private patients, which are unavailable in the public system, has been described as “incredibly unfair” by the Iri(...)